Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL381 Target Snapshot

B16 · CELL-LINE · Mus musculus

Back to Search Search this target Browse approvals Evidence Card
3,211Compounds
1,597Assays
17Approved Drugs
2,469.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Research home Demo workspace
Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats B16 as ChEMBL target CHEMBL381. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
B16
CELL-LINE · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL381
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether B16 still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

Preferred NameB16
Target TypeCELL-LINE
OrganismMus musculus
ChEMBL ↗

Next Actions

SearchRun a focused querySearch the database using this target name as the starting context. ApprovalsCheck approved moleculesSee which approved drugs connect back to this target and its surrounding signal space. FeedScan papers & updatesStay in the project thread while checking recent papers and platform updates.
UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelB16
UniProt AccessionN/A

B16

Source · UniProt accession via ChEMBL component mapping
UniProt Context ↗
Review Cue

How to read this target

Review this target as B16.

Review nameB16
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

17
Approved
1
Phase III
10
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC502,437.0
KI4.0
EC5028.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL265841 10.22 IC50 0.06 Preclinical
CHEMBL423492 9.7 IC50 0.2 Preclinical
CHEMBL441158 9.4 IC50 0.4 Preclinical
CHEMBL4282474 9.3 IC50 0.5 Preclinical
CHEMBL101859 9.05 IC50 0.9 Preclinical
CHEMBL404613 9.0 IC50 1.0 Preclinical
CHEMBL67 9.0 IC50 1.0 Preclinical
CHEMBL106389 8.96 IC50 1.1 Preclinical
CHEMBL69345 8.85 IC50 1.4 Preclinical
CHEMBL306455 8.64 IC50 2.3 Preclinical
Distribution

pChEMBL Value Distribution

378
5.0
233
5.5
90
6.0
96
6.5
35
7.0
51
7.5
26
8.0
12
8.5
5
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

PACLITAXEL
CHEMBL428647
Approved 1992
Properties Compare Identifier
ETOPOSIDE
CHEMBL44657
Approved 1983
Properties Compare Identifier
DAUNORUBICIN
CHEMBL178
Approved 1979
Properties Compare Identifier
DOXORUBICIN
CHEMBL53463
Approved 1974
Properties Compare Identifier
VINCRISTINE
CHEMBL90555
Approved 1963
Properties Compare Identifier
COLCHICINE
CHEMBL107
Approved 1961
Properties Compare Identifier
Assay Landscape

Assay Landscape

1,636
Total Assays
1,487
Tested Compounds
4
Assay Types
Functional — 1,588 assays, 1,487 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 801 4 7.2
cell-based format 787 1,483 5.4
ADME — 45 assays, 22 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 44 22 4.7
organism-based format 1 0 —
Toxicity — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 0 —
Unassigned — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0 —

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine